Semaglutide surgery risk? ultrasound study aims to keep patients safe
NCT ID NCT06420739
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at 100 fasting surgical patients who take semaglutide (a diabetes/weight-loss drug). Doctors will use a bedside ultrasound to check if their stomachs are truly empty before surgery, even after fasting. The goal is to find out how often a 'full stomach' happens and create safer anesthesia guidelines.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- semaglutide
- What this could lead to
- If successful, this could lead to better safety guidelines for surgical patients taking semaglutide, reducing the risk of complications during anesthesia.
- What could go wrong
- This is a small, observational study (100 people) that only looks at one hospital. It won't directly change treatment yet, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FASTING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Toronto Western Hospital
Toronto, Ontario, M5T 2S8, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Three-Day fast reshapes fat cells and boosts fat burning, study hints
- Fasting plus fibre: a Gut-Boosting combo?
- Ramadan dry fasting vs 16:8: which boosts cell cleanup more?
- New pill may help diabetics fast safely during ramadan
- Doctors unite to define safe fasting practices
- New study aims to quench Teens' thirst before surgery: how much clear fluid is safe?